Skip to main content

Table 3 ApoE genotypes and alleles distribution based on MetS presence

From: Diversity of Apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of Metabolic Syndrome among hypertensive patients

 

Total

MetS (+)

Mets (−)

p

(n = 266)

(n = 117)

E4/4

7 (1.8%)

5 (1.9%)

2 (1.7%)

NS

E4/3

56 (14.6%)

37 (13.9%)

19 (16.2%)

NS

E3/3

278 (72.6%)

197 (73.3%)

85 (70.9%)

NS

E3/2

34 (8.9%)

24 (9.0%)

10 (8.5%)

NS

E4/2

8 (2.1%)

5 (1.9%)

3 (2.6%)

NS

E2 allele

42 (11.0%)

29 (10.9%)

13 (11.1%)

NS

E3 allele

368 (96.1%)

256 (96.2%)

112 (95.7%)

NS

E4 allele

71 (18.5%)

47 (17.7%)

24 (20.5%)

NS

  1. Genotypes: E4/4, E 4/3, E 3/3, E 3/2, E 4/2. Alleles: 2,3 and 4. p: NS, non significant.